Induction and Inhibition of Tumor Progression

Proceedings of the Society for Experimental Biology and Medicine

Volumn 202, Issue 1, 1993, Pages 9-15

  Warren, Barbour S ^a   Naylor, Mark F ^a   Winberg, Lloyd D ^a   Yoshimi, Naoki ^a   Volpe, John P G ^a   Gimenez Conti, Irma ^a   Slaga, Thomas J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUTYLATED HYDROXYANISOLE; CARCINOGEN; DISULFIRAM; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; TUMOR PROMOTER;

ANIMAL TISSUE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; CARCINOGENESIS; CARCINOGENICITY; CONFERENCE PAPER; DISEASE COURSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER; TUMOR VOLUME;

ANIMAL; ANTICARCINOGENIC AGENTS; BIOLOGICAL MARKERS; CARCINOGENS; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; MICE; PAPILLOMA; SKIN; SKIN NEOPLASMS;

EID: 0027506021     PISSN: 00379727     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/00379727-202-43511B     Document Type: Article

References (41)

1. Slaga TJ. Cellular and molecular mechanisms involved in multistage skin carcinogenesis. In: Conti CJ, Slaga TJ, Klein-Szanto AJP, Eds. Carcinogenesis—A Comprehensive Survey. New York: Raven Press, Vol II: pp 1–18, 1989.
2. Bishop JM. Molecular themes in oncogenesis. Cell 64:235–248, 1991.
3. Argyris TS. Regeneration and the mechanism of epidermal tumor promotion. CRC Crit Rev Toxicol 14:211–258, 1985.
4. Aldaz CM, Conti CJ, Gimenez IB, Slaga TJ, Klein-Szanto AJP. Cutaneous changes during prolonged application of 12-O-tetra-decanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res 45:2753–2759, 1985.
5. Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J. Tumor progression in SENCAR mouse skin as a function of initiator dose and promoter dose, duration and type. Cancer Res 48:7048–7054, 1988.
6. Aldaz CM, Conti CJ, Chen A, Bianchi A, Walker SB, DiGiovanni J. Promoter independence as a feature of most skin papillomas in SENCAR mice. Cancer Res 51:1045–1050, 1991.
7. Slaga TJ. Mechanisms involved in two-stage carcinogenesis in mouse skin. In: Slaga TJ, Ed. Mechanisms of Tumor Promotion. Boca Raton, FL: CRC Press, Vol I: pp 1–16, 1983.
8. O'Connell JF, Klein-Szanto AJP, DiGiovanni DM, Fries JW, Slaga TJ. Malignant progression of mouse skin papillomas treated with ethylnitrosourea, N-methyl-N'-nitro-N-nitrosoguanidine, or 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett 30:269–274, 1986.
9. Hennings HR, Shores ML, Wenk EF, Spangler R, Tarone R, Yuspa SH. Malignant conversion of mouse skin tumors is increased by tumor initiators and unaffected by tumor promoters. Nature 304:67–69, 1983.
10. Hennings H, Spangler EF, Shores R, Mitchell P, Devor D, Shamsuddin AKM, Elgjo KM, Yuspa SH. Malignant conversion and metastasis of mouse skin tumors: A comparison of SENCAR and CD-1 mice. Environ Health Perspect 68:69–74, 1986.
11. Hennings H, Shores RA, Poirier MC, Reed E, Tarone RE, Yuspa SH. Enhanced malignant conversion of benign mouse skin tumors by cisplatin. JNCI 82:836–840, 1990.
12. Greenhalgh DA, Welty DJ, Player A, Yuspa SH. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proc Natl Acad Sci USA 87:643–647, 1990.
13. Slaga TJ, Klein-Szanto AJP, Triplett LL, Yotti LP. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213:1023–1025, 1981.
14. O'Connell JF, Klein-Szanto AJP, Digiovanni DM, Fries JW, Slaga TJ. Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. Cancer Res 46:2863–2865, 1986.
15. Rotstein JB, O'Connell JF, Slaga TJ. The enhanced progression of papillomas to carcinomas by peroxides in the 2-stage mouse skin model. Proc Am Assoc Cancer Res 27:143, 1986.
16. Saladina AJ, Wiley JC, Lechner JF, Grafstrom RC, LaVeck M, Harris CC. Effects of formaldehyde, acetaldehyde, benzoyl peroxide, and hydrogen peroxide on cultured normal human bronchial epithelial cells. Cancer Res 45:2522–2526, 1985.
17. Hartley JA, Gibson NW, Zwelling LA, Yuspa SH. The association of DNA strand breaks with accelerated terminal differentiation in mouse epidermal cells exposed to tumor promoters. Cancer Res 45:4864–4870, 1985.
18. Gensler HL, Bowden GT. Evidence suggesting a dissociation of DNA strand scissions and late-stage promotion of tumor cell phenotype. Carcinogenesis 4:1507–1511, 1983.
19. Aldaz CM, Conti CJ, Klein-Szanto AJP, Slaga TJ. Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: Relevance to malignancy. Proc Natl Acad Sci USA 84:2029–2032, 1987.
20. Rotstein JB, Slaga TJ. Effect of exogenous glutathione on tumor progression in the murine skin multistage carcinogenesis model. Carcinogenesis 9:1547–1551, 1988.
21. Hartley JA, Gibson NW, Kilkenny A, Yuspa SH. Mouse keratinocytes derived from initiated skin or papillomas are resistant to DNA strand breakage by benzoyl peroxide: A possible mechanism for tumor promotion mediated by benzoyl peroxide. Carcinogenesis 8:1827–1830, 1987.
22. Rotstein JB, Slaga TJ. Acetic acid, a potent agent of tumor progression in the multistage mouse skin model for chemical carcinogenesis. Cancer Lett 42:87–90, 1988.
23. Slaga TJ, Bowden GT, Boutwell RK. Acetic acid, a potent stimulator of mouse epidermal macromolecular synthesis and hyperplasia but with weak tumor-promoting activity. JNCI 55:983–987, 1975.
24. Ames BN, Gold LS. Chemical carcinogenesis: Too many rodent carcinogens. Proc Natl Acad Sci USA 87:772–776, 1990.
25. Fearon ER, Vogelstein B. A genetic model for colorectal carcinogenesis. Cell 61:759–767, 1990.
26. Digiovanni J. Inhibition of chemical carcinogenesis. In: Cooper CS, Grover PL, eds. Chemical Carcinogenesis and Mutagenesis II. Berlin: Springer-Verlag, pp 159–224, 1991.
27. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 202:343–361, 1988.
28. Reiners JJ Jr, Kodari E, Cappel RE, Hilbert HF. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Part II: Quantitation of glutathione and glutathione disulfide. Carcinogenesis 12:2345–2352, 1991.
29. Zemaitis MA, Greene FE. Impairment of hepatic microsomal drug metabolism in the rat during daily disulfuram administration. Biochem Pharmacol 23:1355–1360, 1976.
30. Bertram B, Tacchi AM, Pool BL, Weisler M. In vitro formation of methyl-diethyldithiocarbamate after the reaction of nitrosoacetoxy-methylmethylamine or methylnitrosourea with disulfuram. Carcinogenesis 3:1361–1366, 1982.
31. Bertram B, Frei E, Scherf HR, Schumacher J, Tacchi AM, Wiessler MJ, Influence of a prolonged treatment with disulfuram and D(-)-penicillamine on nitrosodiethylamine induced biological and biochemical effects in rats. J Cancer Res Clin Oncol 109:9–15, 1985.
32. Hanigan MH, Pitot HC. Gamma-glutamyl transpeptidase—its role in hepatocarcinogenesis. Carcinogenesis 6:165–172, 1985.
33. Shirai T, Fujishima S, Oshima M, Masuda A, Ito N. Effects of butylated hydroxyanisole, butylated hydroxytoluene and NaCl on gastric carcinogenesis initiated with N-methyl-N′-nitro-N-nitrosoguanidine in F344 rats. JNCI 72:1189–1198, 1984.
34. Meiser A, Anderson ME. Glutathione. Annu Rev Biochem 52:711–760, 1983.
35. Heisterkamp N, Rajpert-De-Meyts E, Uribe L, Forman HJ, Groffen J. Identification of a human gammaglutamyl cleaving enzyme related to, but distinct from, gammaglutamyl transpeptidase. Proc Natl Acad Sci USA 88:6303–6307, 1991.
36. De Young LM, Richards WL, Bonzelet W, Tsai LL, Boutwell RK. Localization and significance of gammaglutamyl transpeptidase in normal and neoplastic skin. Cancer Res 38:3697–3701, 1978.
37. Klein-Szanto AJP, Nelson KG, Shah Y, Slaga TJS. Simultaneous appearance of keratin modifications and 7-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas. JNCI 70:161–168, 1983.
38. Conti CJ, Fries JW, Viaje A, Miller DR, Morris R, Slaga TJ. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Res 48:435–439, 1988.
39. Stark A-A, Zeiger E, Pagano DA. Glutathione mutagenesis in Salmonella typhimurium TA 100: Dependence on a single enzyme, 7-glutamyl-transpeptidase. Mutat Res 177:42–52, 1987.
40. Stark A-A, Zeiger E, Pagano DA. Glutathione mutagenesis in Salmonella typhimurium is a γ-glutamyl-transpeptidase-enhanced process involving active oxygen species. Carcinogenesis 9:771–777, 1988.
41. Tate SS, Meiser A. Stimulation of the hydrolytic activity and decrease of the transpeptidase activity of γ-glutamyl transpeptidase by maleate; Identity of a rat kidney maleate-stimulated glutaminase and γ-glutamyl transpeptidase. Proc Natl Acad Sci USA 71:3329–3333, 1974.